Opko

Gloved merger acquisitions
MedTech

Sema4 signals $623M bid for genetic testing provider GeneDx

Fresh off a SPAC deal that brought in $500 million in cash proceeds, Sema4 is putting those earnings to good use.
Andrea Park Jan 18, 2022 9:51am
FDA Building 2

Pfizer stumbles close to finish line in growth hormone race

Sep 27, 2021 7:05am
FDA Building

Pfizer, Opko's growth hormone en route to October FDA decision

Jan 4, 2021 9:15am
Pfizer sign

Pfizer presents growth hormone data ahead of FDA filing

Oct 8, 2020 8:35am
Zurich Switzerland

Vifor flies solo, plans spending spree as sister unit files IPO

Apr 7, 2017 2:38am
Research

Pfizer, Opko end 2016 downbeat as hGH-CTP fails phase 3 trial

Dec 30, 2016 9:40am